Tonix Pharmaceuticals releases more data from second positive Phase 3 clinical trial of TNX-102 SL

By Proactive Investors / January 26, 2024 / www.youtube.com / Article Link


Tonix Pharmaceuticals CEO Dr. Seth Lederman joined Steve Darling from Proactive to share additional safety and tolerability data ...

Recent News

Gold stocks slump partly on fears of cost increases

March 09, 2026 / www.canadianminingreport.com

Canadian provinces rank high in Fraser Institute Survey

March 09, 2026 / www.canadianminingreport.com

Major producers and most of TSXV gold see strong gains

March 03, 2026 / www.canadianminingreport.com

Big Gold production declining, revenue surging, costs flat

February 23, 2026 / www.canadianminingreport.com

Gold stocks rise with majors outpaced by juniors

February 23, 2026 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok